You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 126 No. 12, December 1991 TABLE OF CONTENTS
  Archives
  •  Online Features
  PAPERS PRESENTED AT THE 44TH ANNUAL CANCER SYMPOSIUM OF THE SOCIETY OF SURGICAL ONCOLOGY
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (19)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

High-Dose Preoperative Radiation and Radical Sphincter-Preserving Surgery for Rectal Cancer

Gerald Marks, MD; Mohammed Mohiuddin, MD; Arieh Eitan, MD; Luigi Masoni, MD; Jan Rakinic, MD

Arch Surg. 1991;126(12):1534-1540.


Abstract

• To reduce local recurrence associated with rectal cancer and to extend the scope of anal sphincter preservation, a selective program of high-dose preoperative radiation therapy and sphincter-preserving surgery was initiated in 1976. High-energy photon therapy (40 to 60 Gy) was administered in doses of 1.8 to 2.5 Gy during a period of 41/2 to 6 weeks and followed in 4 to 6 weeks with curative sphincter-preserving surgery for clinicopathologically unfavorable and low rectal cancers. None of the 143 patients in the study died during the postoperative period. Fifteen (13%) of 117 patients followed up for at least 24 months experienced local recurrence. Acceptable sphincter function was retained in 130 patients (91%). Our program of high-dose preoperative radiation therapy and sphincter-preserving surgery for the treatment of high-risk cancers, including those in the distal third of the rectum, resulted in better-than-expected survival and control of local recurrence with acceptable morbidity and no mortality.

(Arch Surg. 1991;126:1534-1540)



Author Affiliations

From the Department of Surgery, Division of Colorectal Surgery, The Comprehensive Rectal Cancer Center (Drs Marks and Rakinic) and the Department of Radiation Oncology and Nuclear Medicine (Dr Mohiuddin), Thomas Jefferson University Hospital, Philadelphia, Pa; Rambam University Hospital, Haifa, Israel (Dr Eitan); and La Sapienza University, Rome, Italy (Dr Masoni).


Footnotes

Accepted for publication September 22, 1991.

Presented at the 44th Annual Cancer Symposium of the Society of Surgical Oncology, Orlando, Fla, March 25, 1991.

Reprint requests to The Comprehensive Rectal Cancer Center, 1100 Walnut St, Suite 702, Philadelphia, PA 19107-5098 (Dr Marks).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Influence of the Interval Between Preoperative Radiation Therapy and Surgery on Downstaging and on the Rate of Sphincter-Sparing Surgery for Rectal Cancer: The Lyon R90-01 Randomized Trial
Francois et al.
JCO 1999;17:2396-2396.
ABSTRACT | FULL TEXT  

Recent Advances in Radiation Oncology
Lichter and Lawrence
NEJM 1995;332:371-379.
FULL TEXT  

Cancer of the Rectum: Where Are We? Where Are We Going?
Welch and Welch
Arch Surg 1993;128:697-702.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1991 American Medical Association. All Rights Reserved.